Further re Tender Offer, etc

SMITH AND NEPHEW PLC
1 September 1999


                                     
                       SMITH & NEPHEW'S TENDER OFFER
                      FOR SHARES OF EXOGEN COMPLETED
 
 
Smith & Nephew plc, the worldwide healthcare group, today announced that,
following the tender offer for all of the outstanding share capital of
Exogen, Inc. by one of its subsidiaries, 11,529,197 shares of Exogen stock
have been validly tendered which, together with the shares owned by Smith
& Nephew, represent 96.47% of the outstanding shares and that it expects
to complete the acquisition of Exogen later this month.
 
Exogen, based in the US, is the leading producer of non-invasive
ultrasound devices for accelerated healing of bone fractures.  The tender
offer, which was originally announced on 26 July, was for the 93.6% of
shares in Exogen not already owned by Smith & Nephew for a total price of
£40m.